$59.77
At close: Aug 19, 5:00 PM EST
EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (EVFM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.04 | $0.00 | $-0.01 | $-0.02 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $899000 | $9.6M | $5.0M | $4.8M |
| Surprise | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Apr 27, 2023 | $38.75 | $-26.25 | 247.6 % |
| Q3 | Jan 6, 2023 | $-5.00 | $-31.25 | 84.0 % |
| Q2 | Aug 4, 2022 | $-105.00 | $-120.00 | 12.5 % |
| Q1 | May 4, 2022 | $-360.00 | $-375.00 | 4.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Jun 16, 2023 | $5.81M | $13.50M | -57.0 % |
| Q4 | Apr 27, 2023 | $181.00K | $12.97M | -98.6 % |
| Q3 | Jan 6, 2023 | $6.37M | $9.32M | -31.6 % |
| Q2 | Aug 4, 2022 | $6.03M | $5.97M | 1.07 % |